Ocular Therapeutix™ Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Ocular Therapeutix (OCUL) Misses Q3 EPS by 9c
November 10, 2015 4:35 PM ESTOcular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.47), $0.09 worse than the analyst estimate of ($0.38).
The third quarter 2015 results include $1.2 million in non-cash charges for stock-based compensation compared to $0.6 million in the third quarter of 2014.
As of September 30, 2015, cash and cash equivalents and marketable... More
